Immunobiology of Merkel cell carcinoma: Implications for immunotherapy of a polyomavirus-associated cancer

Current Oncology Reports

Volumn 13, Issue 6, 2011, Pages 488-497

  Bhatia, Shailender ^a   Afanasiev, Olga ^a   Nghiem, Paul ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cancer virus; Immune escape; Immune evasion; Immune suppression; Immunotherapy; MCPyV; MCV; Merkel cell carcinoma; Merkel cell polyomavirus; MHC; T antigen; TILs; Tumor immunology; Tumor infiltrating lymphocytes; Viral cancer; Viral oncoproteins

Indexed keywords

FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 21; IPILIMUMAB; TRANSFORMING GROWTH FACTOR ALPHA; VIRUS DNA;

ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER RISK; CELL CYCLE PROGRESSION; CLINICAL FEATURE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG TARGETING; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; MERKEL CELL TUMOR; MOLECULAR EPIDEMIOLOGY; MOLECULAR PATHOLOGY; NONHUMAN; POLYOMA VIRUS; RISK ASSESSMENT; VIRUS CARCINOGENESIS; VIRUS IDENTIFICATION; VIRUS INFECTION;

ANTIBODIES, VIRAL; CARCINOMA, MERKEL CELL; HUMANS; IMMUNITY, CELLULAR; IMMUNOTHERAPY; MERKEL CELL POLYOMAVIRUS; SKIN NEOPLASMS;

EID: 81155148209     PISSN: 15233790     EISSN: 15346269     Source Type: Journal    
DOI: 10.1007/s11912-011-0197-5     Document Type: Article

References (98)

1. • Lemos BD, Storer, BE, Iyer, JG, et al.: Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5,823 cases as the basis of the first consensus staging system for this cancer. J Am Acad Dermatol. 2010. A publication especially relevant to the clinician, as it determines the prognostic significance of tumor size, clinical versus pathologic nodal evaluation, and extent of disease at presentation and thereby derives the first consensus staging/prognostic system for MCC.
2. B Lemos P Nghiem 2007 Merkel cell carcinoma: more deaths but still no pathway to blame J Invest Dermatol 127 2100 2103 17700621 10.1038/sj.jid.5700925 1:CAS:528:DC%2BD2sXptVWht70%3D (Pubitemid 47258499)
3. Albores-Saavedra J, Batich, K, Chable-Montero, F, et al.: Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol. 2009.
4. NC Hodgson 2005 Merkel cell carcinoma: changing incidence trends J Surg Oncol 89 1 4 15611998 10.1002/jso.20167 (Pubitemid 40075960)
5. R Moll A Löwe J Laufer WW Franke 1992 Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies Am J Pathol 140 427 447 1371204 1:STN:280:DyaK387lt1ehsA%3D%3D
6. M Heath N Jaimes B Lemos, et al. 2008 Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features J Am Acad Dermatol 58 375 381 18280333 10.1016/j.jaad.2007.11.020 (Pubitemid 351226308)
7. MA Weinstock B Gardstein 1999 Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality Am J Publ Health 89 1240 1244 10.2105/AJPH.89.8.1240 1:STN:280:DyaK1MzmtFGrsw%3D%3D (Pubitemid 29359582)
8. American Cancer Society. Cancer facts & figures 2006. Atlanta: American Cancer Society; 2006.
9. PT Tai E Yu E Winquist, et al. 2000 Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases J Clin Oncol 18 2493 2499 10856110 1:CAS:528:DC%2BD3cXkvFWrsbk%3D (Pubitemid 30415837)
10. I Penn 1999 Posttransplant malignancies Transplant Proc 31 1260 1262 10083562 10.1016/S0041-1345(98)01987-3 1:STN:280:DyaK1M7otlWgsw%3D%3D (Pubitemid 29127895)
11. M Agelli LX Clegg 2003 Epidemiology of primary Merkel cell carcinoma in the United States J Am Acad Dermatol 49 832 841 14576661 10.1016/S0190-9622(03) 02108-X (Pubitemid 37314870)
12. EA Engels M Frisch JJ Goedert, et al. 2002 Merkel cell carcinoma and HIV infection Lancet 359 497 498 11853800 10.1016/S0140-6736(02)07668-7 (Pubitemid 34164301)
13. J Burack EL Altschuler 2003 Sustained remission of metastatic Merkel cell carcinoma with treatment of HIV infection J R Soc Med 96 238 239 12724438 10.1258/jrsm.96.5.238 (Pubitemid 36561074)
14. Muirhead R, Ritchie DM. Partial regression of Merkel cell carcinoma in response to withdrawal of azathioprine in an immunosuppression-induced case of metastatic Merkel cell carcinoma. Clin Oncol (R Coll Radiol). 2007;19.
15. RW Miller CS Rabkin 1999 Merkel cell carcinoma and melanoma: etiological similarities and differences Cancer Epidemiol Biomarkers Prev 8 153 158 10067813 1:STN:280:DyaK1M7msFWgtA%3D%3D (Pubitemid 29085382)
16. D Pan D Narayan S Ariyan 2002 Merkel cell carcinoma: five case reports using sentinel lymph node biopsy and a review of 110 new cases Plast Reconstr Surg 110 1259 1265 12360064 10.1097/00006534-200210000-00007
17. PD Karkos A Sastry S Hampal M Al-Jafari 2010 Spontaneous regression of Merkel cell carcinoma of the nose Head Neck 32 411 414 19373785
18. H Kubo S Matsushita T Fukushige, et al. 2007 Spontaneous regression of recurrent and metastatic Merkel cell carcinoma J Dermatol 34 773 777 17973819 10.1111/j.1346-8138.2007.00382.x (Pubitemid 350029298)
19. Wooff JC, Trites, JR, Walsh, NMG, Bullock, MJ: Complete spontaneous regression of metastatic Merkel cell carcinoma: a case report and review of the literature. Am J Dermatopathol. 2010.
20. C Ciudad JA Avilés F Alfageme, et al. 2010 Spontaneous regression in merkel cell carcinoma: report of two cases with a description of dermoscopic features and review of the literature Dermatol Surg 36 687 693 20384741 10.1111/j.1524-4725.2010.01531.x 1:CAS:528:DC%2BC3cXlvFeitLs%3D
21. H Feng M Shuda Y Chang PS Moore 2008 Clonal integration of a polyomavirus in human Merkel cell carcinoma Science 319 1096 1100 18202256 10.1126/science.1152586 1:CAS:528:DC%2BD1cXit1yhsbY%3D The original publication identifying the novel Merkel cell polyomavirus and its association with MCC (Pubitemid 351300792)
22. KM Garneski AH Warcola Q Feng, et al. 2009 Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors J Investig Dermatol 129 246 248 18650846 10.1038/jid.2008.229 1:CAS:528:DC%2BD1cXhsVymu77N
23. JC Becker R Houben S Ugurel, et al. 2009 MC polyomavirus is frequently present in Merkel cell carcinoma of European patients J Invest Dermatol 129 248 250 18633441 10.1038/jid.2008.198 1:CAS:528:DC%2BD1cXhsVymu7%2FJ
24. A Kassem A Schöpflin C Diaz, et al. 2008 Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene Cancer Res 68 5009 5013 18593898 10.1158/0008-5472.CAN-08-0949 1:CAS:528:DC%2BD1cXnvFOqt70%3D
25. H Katano H Ito Y Suzuki, et al. 2009 Detection of Merkel cell polyomavirus in Merkel cell carcinoma and Kaposi's sarcoma J Med Virol 81 1951 1958 19774683 10.1002/jmv.21608 1:CAS:528:DC%2BD1MXhtleitbjN
26. R Houben M Shuda R Weinkam, et al. 2010 Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T-antigens J Virol 84 7064 7072 20444890 10.1128/JVI.02400-09 1:CAS:528:DC%2BC3cXhtVWls7jM This article reports that MCC cells depend on persistent expression of MCPyV oncoproteins and supports causative role of MCPyV and therapeutic targeting of viral oncoproteins
27. JJ Carter KG Paulson GC Wipf, et al. 2009 Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma J Natl Cancer Inst 101 1510 1522 19776382 10.1093/jnci/djp332 1:CAS:528:DC%2BD1MXhsVWnu7%2FN
28. MP Pulitzer BD Amin KJ Busam 2009 Merkel cell carcinoma: review Adv Anat Pathol 16 135 144 19395876 10.1097/PAP.0b013e3181a12f5a
29. JM Kean S Rao M Wang RL Garcea 2009 Seroepidemiology of human polyomaviruses PLoS Pathog 5 e1000363 19325891 10.1371/journal.ppat.1000363
30. YL Tolstov DV Pastrana H Feng, et al. 2009 Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays Int J Cancer 125 1250 1256 19499548 10.1002/ijc.24509 1:CAS:528:DC%2BD1MXovVeltrg%3D
31. DV Pastrana YL Tolstov JC Becker, et al. 2009 Quantitation of human Seroresponsiveness to Merkel cell polyomavirus PLoS Pathog 1 20
32. Touze A, Le Bidre, E, Laude, H, et al.: High levels of antibodies against Merkel cell polyomavirus identify a subset of patients with Merkel cell carcinoma with better clinical outcome. J Clin Oncol. 2011:1-9
33. RM Schowalter DV Pastrana KA Pumphrey, et al. 2011 Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin Cell Host and Microbe 7 509 515 10.1016/j.chom.2010.05.006
34. V Foulongne N Kluger O Dereure, et al. 2010 Merkel cell polyomavirus in cutaneous swabs Emerging Infect Dis 16 685 687 20350388
35. U Wieland S Silling N Scola, et al. 2011 Merkel cell polyomavirus infection in HIV-positive men Arch Dermatol 147 401 406 21482890 10.1001/archdermatol.2011.42
36. AM Dworkin SY Tseng DC Allain, et al. 2009 Merkel cell polyomavirus in cutaneous squamous cell carcinoma of immunocompetent individuals J Invest Dermatol 129 2868 2874 19554019 10.1038/jid.2009.183 1:CAS:528: DC%2BD1MXhtl2jsL3I
37. Loyo M, Guerrero-Preston, R, Brait, M, et al.: Quantitative detection of Merkel cell virus in human tissues and possible mode of transmission. Int J Canc. 2010;NA-NA.
38. K Kantola M Sadeghi A Lahtinen, et al. 2009 Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: implications for respiratory transmission and latency J Clin Virol 45 292 295 19464943 10.1016/j.jcv.2009.04.008 1:CAS:528:DC%2BD1MXosVahtLg%3D
39. M Babakir-Mina M Ciccozzi A Lo Presti, et al. 2010 Identification of Merkel cell polyomavirus in the lower respiratory tract of Italian patients J Med Virol 82 505 509 20087943 10.1002/jmv.21711 1:CAS:528:DC%2BC3cXitlKntLs%3D
40. S Bialasiewicz SB Lambert DM Whiley, et al. 2009 Merkel cell polyomavirus DNA in respiratory specimens from children and adults Emerg Infect Dis 15 492 494 19239774 10.3201/eid1503.081067 1:CAS:528:DC%2BD1MXjs12qs74%3D
41. S Goh C Lindau A Tiveljung-Lindell T Allander 2009 Merkel cell polyomavirus in respiratory tract secretions Emerg Infect Dis 15 489 491 19239773 10.3201/eid1503.081206
42. PS Moore Y Chang 2010 Why do viruses cause cancer? Highlights of the first century of human tumour virology Nat Rev Canc 10 878 889 10.1038/nrc2961 1:CAS:528:DC%2BC3cXhsVOrsbrN An excellent review of viral carcinogenesis
43. BE Eddy GS Borman GE Grubbs RD Young 1962 Identification of the oncogenic substance in rhesus monkey kidney cell culture as simian virus 40 Virology 17 65 75 13889129 10.1016/0042-6822(62)90082-X 1:STN:280:DyaF38%2FjtVCntQ%3D%3D
44. M Shuda H Feng HJ Kwun, et al. 2008 T-antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus Proc Natl Acad Sci USA 105 16272 16277 18812503 10.1073/pnas.0806526105 1:CAS:528:DC%2BD1cXht12qtLrL The first of several publications that identified tumor-specific truncating mutations in MCPyV T-antigen DNA
45. SH Ali JA DeCaprio 2001 Cellular transformation by SV40 large T-antigen: interaction with host proteins Semin Canc Biol 11 15 23 10.1006/scbi.2000.0342 1:CAS:528:DC%2BD3MXhslSntLc%3D (Pubitemid 32222747)
46. Houben R, Adam, C, Baeurle, A, et al.: An intact retinoblastoma protein binding site in merkel cell polyomavirus large T-antigen is required for promoting growth of merkel cell carcinoma cells. Int J Canc Journal international du cancer. 2011.
47. H Sihto HM Kukko VS Koljonen, et al. 2011 Merkel cell polyomavirus infection, large T-antigen, retinoblastoma protein and outcome in Merkel cell carcinoma Clin Canc Res 1 9
48. K Bhatia JJ Goedert R Modali, et al. 2010 Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression Int J Canc Journal international du cancer 126 2240 2246 1:CAS:528: DC%2BC3cXisFemt7k%3D
49. K Segawa A Minowa K Sugasawa, et al. 1993 Abrogation of p53-mediated transactivation by SV40 large T-antigen Oncogene 8 543 548 8382354 1:CAS:528:DyaK3sXhvVOksb4%3D (Pubitemid 23093115)
50. D Jiang A Srinivasan G Lozano PD Robbins 1993 SV40 T-antigen abrogates p53-mediated transcriptional activity Oncogene 8 2805 2812 8378089 1:CAS:528:DyaK3sXms1yntrw%3D (Pubitemid 23279109)
51. M Oren W Maltzman AJ Levine 1981 Post-translational regulation of the 54 K cellular tumor antigen in normal and transformed cells Mol Cell Biol 1 101 110 6100960 1:CAS:528:DyaL3MXhtF2itrw%3D (Pubitemid 11103325)
52. JM Pipas AJ Levine 2001 Role of T-antigen interactions with p53 in tumorigenesis Semin Canc Biol 11 23 30 10.1006/scbi.2000.0343 1:CAS:528:DC%2BD3MXhslSntb4%3D (Pubitemid 32222748)
53. D Ahuja MT Sáenz-Robles JM Pipas 2005 SV40 large T-antigen targets multiple cellular pathways to elicit cellular transformation Oncogene 24 7729 7745 16299533 10.1038/sj.onc.1209046 1:CAS:528:DC%2BD2MXht1aqsrvN (Pubitemid 41670675)
54. M Schmid K Janssen B Dockhorn-Dworniczak, et al. 1997 p53 abnormalities are rare events in neuroendocrine (Merkel cell) carcinoma of the skin. An immunohistochemical and SSCP analysis Virchows Arch 430 233 237 9099981 10.1007/BF01324807 1:CAS:528:DyaK2sXit1ektbw%3D (Pubitemid 27151934)
55. M Van Gele M Kaghad JH Leonard, et al. 2000 Mutation analysis of P73 and TP53 in Merkel cell carcinoma Br J Canc 82 823 826 10.1054/bjoc.1999.1006 (Pubitemid 30085233)
56. Bhatia K, Goedert, JJ, Modali, R, et al.: Immunological detection of viral large T-antigen identifies a subset of merkel cell carcinoma tumors with higher viral abundance and better clinical outcome. Int J Canc Journal international du cancer. 2009.
57. Waltari M, Sihto, H, Kukko, H, et al.: Association of Merkel cell polyomavirus infection with tumor p53, KIT, stem cell factor, PDGFR-alpha and survival in Merkel cell carcinoma. Int J Canc Journal international du cancer. 2010.
58. M Shuda R Arora HJ Kwun, et al. 2009 Human Merkel cell polyomavirus infection I. MCV T-antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors Int J Canc 125 1243 1249 10.1002/ijc.24510 1:CAS:528:DC%2BD1MXovVeltrY%3D
59. H Faust DV Pastrana CB Buck, et al. 2011 Antibodies to Merkel cell polyomavirus correlate to presence of viral DNA in the skin J Infect Dis 203 1096 1100 21450999 10.1093/infdis/jiq173 1:CAS:528:DC%2BC3MXkt1KiurY%3D
60. • Paulson KG, Carter, JJ, Johnson, LG, et al.: Antibodies to Merkel cell polyomavirus T-antigen oncoproteins reflect tumor burden in Merkel cell carcinoma patients. Canc Res. 2010. This report identifies a potential biomarker to track MCC burden and predict relapse prior to conventional clinical approaches.
61. T Nakamura Y Sato D Watanabe, et al. 2010 Nuclear localization of Merkel cell polyomavirus large T-antigen in Merkel cell carcinoma Virology 398 273 279 20074767 10.1016/j.virol.2009.12.024 1:CAS:528:DC%2BC3cXhs1yhur0%3D
62. AA Andea DG Coit B Amin KJ Busam 2008 Merkel cell carcinoma: histologic features and prognosis Cancer 113 2549 2558 18798233 10.1002/cncr.23874
63. • Paulson KG, Iyer, JG, Tegeder, AR, et al.: Transcriptome-wide studies of Merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol. 2011. This report underscores the importance of immune cell infiltration in MCC tumors and its association with improved prognosis, hence supporting the use of immunotherapy in MCC.
64. GP Dunn AT Bruce H Ikeda, et al. 2002 Cancer immunoediting: from immunosurveillance to tumor escape Nat Immunol 3 991 998 12407406 10.1038/ni1102-991 1:CAS:528:DC%2BD38Xot1Chs70%3D This is an excellent summary of key steps in tumor immune evasion (Pubitemid 35363648)
65. TH Hansen M Bouvier 2009 MHC class I antigen presentation: learning from viral evasion strategies Nat Rev Immunol 9 503 513 19498380 10.1038/nri2575 1:CAS:528:DC%2BD1MXmvVWnsbo%3D
66. M Haque K Ueda K Nakano, et al. 2001 Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded by Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 J Gen Virol 82 1175 1180 11297692 1:CAS:528:DC%2BD3MXjtFOitrw%3D (Pubitemid 32454617)
67. H Hayashi K Tanaka F Jay, et al. 1985 Modulation of the tumorigenicity of human adenovirus-12-transformed cells by interferon Cell 43 263 267 4075396 10.1016/0092-8674(85)90031-5 1:CAS:528:DyaL28XhvVCrsA%3D%3D (Pubitemid 16199712)
68. A Hill P Jugovic I York, et al. 1995 Herpes simplex virus turns off the TAP to evade host immunity Nature 375 411 415 7760935 10.1038/375411a0 1:CAS:528:DyaK2MXmtVehsbc%3D
69. LA Koopman AR van Der Slik MJ Giphart GJ Fleuren 1999 Human leukocyte antigen class I gene mutations in cervical cancer J Natl Canc Inst 91 1669 1677 10.1093/jnci/91.19.1669 1:CAS:528:DyaK1MXmvVynurk%3D (Pubitemid 29479935)
70. FV Cromme PF van Bommel JM Walboomers, et al. 1994 Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours Br J Canc 69 1176 1181 10.1038/bjc.1994.231 1:STN:280: DyaK2c3lslCmsQ%3D%3D (Pubitemid 24161883)
71. B Seliger MJ Maeurer S Ferrone 1997 TAP off-tumors on Immunol Today 18 292 299 9190116 10.1016/S0167-5699(97)01052-9 1:CAS:528:DyaK2sXktVKht7c%3D (Pubitemid 27261449)
72. A Takaoka S Hayakawa H Yanai, et al. 2003 Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence Nature 424 516 523 12872134 10.1038/nature01850 1:CAS:528:DC%2BD3sXlvVGisLw%3D (Pubitemid 36975769)
73. YE Chin M Kitagawa WC Su, et al. 1996 Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1 Science 272 719 722 8614832 10.1126/science.272.5262.719 1:CAS:528:DyaK28Xislamtrs%3D
74. JJ Goronzy W-W Lee CM Weyand 2007 Aging and T-cell diversity Exp Gerontol 42 400 406 17218073 10.1016/j.exger.2006.11.016 1:CAS:528:DC%2BD2sXkt1aku7w%3D (Pubitemid 46561179)
75. A Mogha A Fautrel N Mouchet, et al. 2010 Merkel cell polyomavirus small T-antigen mRNA level is increased following in vivo UV-radiation PLoS ONE 5 e11423 20625394 10.1371/journal.pone.0011423
76. SE Ullrich 2005 Mechanisms underlying UV-induced immune suppression Mutat Res 571 185 205 15748647 10.1016/j.mrfmmm.2004.06.059 1:CAS:528: DC%2BD2MXhvVGhsrk%3D (Pubitemid 40313441)
77. RD Granstein MS Matsui 2004 UV radiation-induced immunosuppression and skin cancer Cutis; cutaneous medicine for the practitioner 74 4 9 15603215 (Pubitemid 39612326)
78. GM Halliday R Bestak KS Yuen, et al. 1998 UVA-induced immunosuppression Mutat Res 422 139 145 9920438 10.1016/S0027-5107(98)00185-7 1:CAS:528: DyaK1cXmvFWmt7w%3D (Pubitemid 28515622)
79. BA Teicher 2007 Transforming growth factor-beta and the immune response to malignant disease Clin Canc Res 13 6247 6251 10.1158/1078-0432.CCR-07-1654 1:CAS:528:DC%2BD2sXht1Cgtb7P (Pubitemid 350075011)
80. A Houston MW Bennett GC O'Sullivan, et al. 2003 Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-beta expression Br J Canc 89 1345 1351 10.1038/sj.bjc.6601240 1:CAS:528:DC%2BD3sXns1Cmuro%3D (Pubitemid 37363427)
81. HT Khong NP Restifo 2002 Natural selection of tumor variants in the generation of "tumor escape" phenotypes Nat Immunol 3 999 1005 12407407 10.1038/ni1102-999 1:CAS:528:DC%2BD38Xot1Chs7o%3D (Pubitemid 35363649)
82. N Rubinstein JM Ilarregui MA Toscano GA Rabinovich 2004 The role of galectins in the initiation, amplification and resolution of the inflammatory response Tissue Antigens 64 1 12 15191517 10.1111/j.0001-2815.2004.00278.x 1:CAS:528:DC%2BD2cXmtlSnurw%3D (Pubitemid 38850363)
83. C Uyttenhove L Pilotte I Théate, et al. 2003 Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase Nat Med 9 1269 1274 14502282 10.1038/nm934 1:CAS:528:DC%2BD3sXns1Clu7c%3D (Pubitemid 37279849)
84. T Wang G Niu M Kortylewski, et al. 2004 Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells Nat Med 10 48 54 14702634 10.1038/nm976 (Pubitemid 38524698)
85. V Groh R Rhinehart J Randolph-Habecker, et al. 2001 Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells Nat Immunol 2 255 260 11224526 10.1038/85321 1:CAS:528: DC%2BD3MXhvVaksr8%3D (Pubitemid 33706003)
86. M Terabe JA Berzofsky 2004 Immunoregulatory T cells in tumor immunity Curr Opin Immunol 16 157 162 15023407 10.1016/j.coi.2004.01.010 1:CAS:528:DC%2BD2cXitFKksrc%3D (Pubitemid 38332026)
87. W Zou 2006 Regulatory T cells, tumour immunity and immunotherapy Nat Rev Immunol 6 295 307 16557261 10.1038/nri1806 1:CAS:528:DC%2BD28XivVyru7k%3D
88. S Kusmartsev S Nagaraj DI Gabrilovich 2005 Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells J Immunol 175 4583 4592 16177103 1:CAS:528:DC%2BD2MXhtVWltbjM (Pubitemid 41361997)
89. AJ Zajac JN Blattman K Murali-Krishna, et al. 1998 Viral immune evasion due to persistence of activated T cells without effector function J Exp Med 188 2205 2213 9858507 10.1084/jem.188.12.2205 1:CAS:528:DyaK1MXhtFaqsg%3D%3D (Pubitemid 29028493)
90. A Gallimore A Glithero A Godkin, et al. 1998 Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes J Exp Med 187 1383 1393 9565631 10.1084/jem.187.9.1383 1:CAS:528:DyaK1cXivVGjtLo%3D (Pubitemid 28215398)
91. EJ Wherry JN Blattman K Murali-Krishna, et al. 2003 Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment J Virol 77 4911 4927 12663797 10.1128/JVI.77.8.4911-4927.2003 1:CAS:528:DC%2BD3sXivFWit74%3D (Pubitemid 36402840)
92. DL Barber EJ Wherry D Masopust, et al. 2006 Restoring function in exhausted CD8 T cells during chronic viral infection Nature 439 682 687 16382236 10.1038/nature04444 1:CAS:528:DC%2BD28XhtFyktL0%3D (Pubitemid 43237609)
93. J Kim JM Mcniff 2008 Nuclear expression of survivin portends a poor prognosis in Merkel cell carcinoma Mod Pathol 21 764 769 18425079 10.1038/modpathol.2008.61 1:CAS:528:DC%2BD1cXmtFGntLs%3D (Pubitemid 351744848)
94. HM Ames CK Bichakjian GY Liu, et al. 2011 Huntingtin-interacting protein 1: a Merkel cell carcinoma marker that interacts with c-Kit J Invest Dermatol 1 8
95. MA Curran M Kim W Montalvo, et al. 2011 Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production PLoS ONE 6 e19499 21559358 10.1371/journal.pone.0019499 1:CAS:528:DC%2BC3MXlsl2gtLc%3D
96. A Palazon A Teijeira I Martinez-Forero, et al. 2011 Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes Canc Res 71 801 811 10.1158/0008-5472.CAN-10-1733 1:CAS:528:DC%2BC3MXhsVCisbo%3D
97. Iyer JG, Afanasiev OK, McClurkan C, et al. Merkel cell polyomavirus-specific CD8+ and CD4+ T-cell responses identified in Merkel cell carcinomas and blood. Clin Cancer Res. 2011; doi: 10.1158/1078-0432.CCR-11-1513.
98. Shuda M, Kwun HJ, Feng H, et al. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. J Clin Investig. 2011; doi: 10.1172/JCI46323.